Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions
WIREs Computational Molecular Science · 2025-11 · 15 (6)
DOI: 10.1002/wcms.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift WIREs Computational Molecular Science, online erschienen am 09.11.2025. Verfasst von Xiaoqing Ru und 4 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 124 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Polypharmacy has become a routine practice in modern medicine, yet the risks of drug–drug interactions (DDIs) remain a critical challenge for patient safety. Given the vast number of possible drug combinations and the impracticality of exhaustive clinical testing, computational approaches have become indispensable for DDI prediction. Over the past 15 years, the field has shifted from handcrafted, similarity‐based models to deep learning and graph neural networks (GNNs). Prediction tasks have also expanded from binary classification to multi‐class, multi‐label, cold‐start, and higher‐order settings. These reflect an emerging paradigm in both methodology and scope. Yet critical bottlenecks remain. Data sparsity, unreliable negatives, class imbalance, and source heterogeneity undermine robustness; models still struggle with generalization to unseen drugs, with mechanistic interpretability, and with capturing asymmetric or higher‐order interactions. These limitations continue to impede translation into clinical and regulatory practice. In this Advanced Review, we critically assess methodological evolution, benchmark datasets, and emerging paradigms, including GNNs, large language models (including multimodal extensions), and generative AI, and examine their promises and limitations. We argue that next‐generation progress hinges on unified multimodal and mechanism‐aware frameworks, strategies for robust learning under cold‐start and long‐tail scenarios, and the integration of causal inference with generative approaches to enhance interpretability. By synthesizing past advances with forward‐looking perspectives, this review outlines strategic pathways for accelerating the transition of DDI prediction toward intelligent, interpretable, and clinically actionable solutions. This article is categorized under: Data Science > Artificial Intelligence/Machine Learning Data Science > Chemoinformatics Molecular and Statistical Mechanics > Molecular Interactions
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ru, X., Li, Z., Wei, L., Liu, Y., & Zou, Q. (2025). Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions. WIREs Computational Molecular Science, 15(6). https://doi.org/10.1002/wcms.70056
Vancouver
Ru X, Li Z, Wei L, Liu Y, Zou Q. Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions. WIREs Computational Molecular Science. 2025;15(6). doi:10.1002/wcms.70056
BibTeX
@article{Ru2025,
author = {Ru, Xiaoqing and Li, Zhen and Wei, Leyi and Liu, Yuanan and Zou, Quan},
title = {Drug–Drug Interaction Prediction: Paradigm Shifts, Key Bottlenecks, and Future Directions},
journal = {WIREs Computational Molecular Science},
year = {2025},
volume = {15},
number = {6},
doi = {10.1002/wcms.70056}
}
EUVIMED